BTG International Inc.

300 Four Falls Corporate Center Ste 300, Conshohocken, Pennsylvania, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

41.7%

Phase 1

16.7%

Phase 4

8.3%

Trial Status Distribution

Approved For Marketing

8.3%

Completed

66.7%

Terminated

25.0%

Clinical Trials

Trials sponsored by this organization (12)

A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.

Completed

observational

Jun 2023101 participants

Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation

Phase 4

Completed

interventional

Jul 201374 participants

Copperhead Envenomation Observational Study

Completed

observational

Jul 201220 participants

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

Phase 1

Completed

interventional

Nov 200950 participants

High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma

Phase 2

Terminated

interventional

Oct 20087 participants

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Phase 2

Terminated

interventional

Sep 20081 participant

Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension

Phase 2

Terminated

interventional

Jun 200820 participants

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

Phase 1

Completed

interventional

May 200820 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations